proxyvotesnow.com

Home › Upcoming votes › Change Agents Corporation.

Change Agents Corporation. Special Meeting, October 30, 2026: Ballot and Results

Merger or special meeting

This meeting took place on October 30, 2026. Change Agents Corporation. reported the official results on Form 8-K, filed October 30, 2026 (read it on EDGAR); they are listed below.

The deadline as the proxy statement states it: “voting facilities for stockholders of record will be available 24 hours a day until 11:59 p.m. Eastern Time on October 29, 2026”. Shares held through a bank, a broker or a company plan can have a different deadline; the voting instruction form says.

Read the proxy statement on EDGAR

What’s on the ballot

Ballot read from the proxy statement and checked. As listed in Change Agents Corporation.’s proxy statement, with the board’s recommendation on each item.

#ItemProposed byBoard recommendsLast year (same kind of item)
1 THE ELOC PROPOSAL Board For —
2 THE ELOC WARRANT SHARES PROPOSAL Board For —
3 THE FUTURE ISSUANCES PROPOSAL Board For —
4 THE FEBRUARY 11TH NOTE CONVERSION PROPOSAL Board For —
5 THE FEBRUARY 19TH NOTE CONVERSION PROPOSAL Board For —
6 THE FORBEARANCE SHARES PROPOSAL Board For —
7 THE CHARTER AMENDMENT PROPOSAL Board For —
8 THE JULY 1ST CONSULTANT SHARES PROPOSAL Board For —
9 THE FIRST JULY 30TH CONSULTANT SHARES PROPOSAL Board For —
10 THE SECOND JULY 30TH CONSULTANT SHARES PROPOSAL Board For —
11 THE AUGUST 1ST CONSULTANT SHARES PROPOSAL Board For —
12 THE PRE-FUNDED WARRANT PROPOSAL Board For —
13 THE MFN SHARES PROPOSAL Board For —
14 SEPTEMBER 2026 PRE-FUNDED WARRANT PROPOSAL Board For —
15 WAIVER PRE-FUNDED WARRANT PROPOSAL Board For —
16 APPROVAL OF THE EQUITY PLAN AMENDMENT PROPOSAL Board For —
17 THE ADJOURNMENT PROPOSAL
Adjournment
Board For —

Last year’s official results

From Change Agents Corporation.’s Form 8-K, filed January 5, 2026, for the meeting held December 30, 2025 (read it on EDGAR). Support is the share of votes cast that were FOR: abstentions and broker non-votes are left out.

ItemSupport (of votes cast)Reported outcome
Elect Director: Wenzhao "Daniel" Lu98%—
Elect Director: Lourdes Felix96%—
Elect Director: Steven A. Sanders95%—
Elect Director: William B. Stilley, III92%—
Elect Director: Wilbert J. Tauzin II98%—
Elect Director: Tevi Troy95%—
2. Ratification of Independent Registered Public Accounting Firm99.7%Approved

Official results of this meeting

ItemSupport (of votes cast)Reported outcome
1. Approved the potential issuance, for the purposes of complying with Nasdaq Listing Rule 5635(d), of the Company's common stock pursuant t99%Approved
2. Approved, for the purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of 46,297 shares of the Company's common stock iss99%Approved
3. Approved, for the purposes of complying with Nasdaq Listing Rule 5635(d), any 20% Issuance (as defined in the Company's Definitive Proxy 98%Approved
4. Approved, for the purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of the Company's common stock issuable upon conver99.1%Approved
5. Approved, for the purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of the Company's common stock issuable upon the co99.1%Approved
6. Approved, for the purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of 18,000 shares of the Company's common stock pur99.3%Approved
7. Approved an amendment to the Company's Amended and Restated Certificate of Incorporation, as amended, to increase the number of authorize86%Approved
8. Approved, for the purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of 15,000 shares of our common stock pursuant to t99%Approved
9. Approved, for the purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of 30,000 shares of our common stock pursuant to t99%Approved
10. Approved, for the purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of 37,500 shares of our common stock pursuant to 99%Approved
11. Approved, for the purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of 10,000 shares of our common stock pursuant to 99%Approved
12. Approved, for the purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of a pre-funded warrant to purchase 50,000 shares99.2%Approved
13. Approved, for the purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of 15,000 shares of our common stock in respect o99.0%Approved
14. Approved, for the purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of a pre-funded warrant to purchase 100,000 share99.0%Approved
15. Approved, for the purposes of complying with Nasdaq Listing Rule 5635(d), the issuance of pre-funded warrants to purchase 84,000 shares 99.0%Approved
16. Approved Amendment No. 1 to the Avalon GloboCare Corp. Stock Incentive Plan (the "Equity Plan Amendment Proposal"); and93%Approved
17. Approved the adjournment of the Special Meeting, if necessary or advisable, to solicit additional proxies in favor of any of the foregoi87%Approved

Filings for this meeting

About this page

The meeting facts and ballot come from the SEC proxy filings listed above. Ballots are read from the proxy statement and checked against the filing’s own text; when that check does not pass, the page shows “see the proxy statement” instead of a ballot. Last year’s figures are the company’s official Form 8-K results and the managers’ Form N-PX reports. Nothing on this page predicts how any shareholder will vote, and it is not investment advice. How this works.